Drug record
What four public record sets show for zolpidem. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.035 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $77.8 million | Details |
| FDA recall records | 10 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Zolpidem Tartrate 5 Mg Tablet: pharmacies pay about $0.035 each, or $1.04 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| ZOLPIDEM TART 1.75 MG TAB SL | Generic | $4.92 per each | $147.52 | Oct 21, 2026 |
| ZOLPIDEM TART 3.5 MG TABLET SL | Generic | $5.80 per each | $173.99 | Oct 21, 2026 |
| ZOLPIDEM TART ER 12.5 MG TAB | Generic | $0.118 per each | $3.54 | Oct 21, 2026 |
| ZOLPIDEM TART ER 6.25 MG TAB | Generic | $0.102 per each | $3.07 | Oct 21, 2026 |
| ZOLPIDEM TARTRATE 10 MG TABLET | Generic | $0.039 per each | $1.17 | Oct 21, 2026 |
| ZOLPIDEM TARTRATE 5 MG TABLET | Generic | $0.035 per each | $1.04 | Oct 21, 2026 |
| ZOLPIDEM TARTRATE 7.5 MG CAP | Generic | $7.99 per each | $239.68 | Oct 21, 2026 |
| AMBIEN 10 MG TABLET | Brand | $22.61 per each | $678.40 | Oct 21, 2026 |
| AMBIEN CR 12.5 MG TABLET | Brand | $22.57 per each | $677.18 | Oct 21, 2026 |
| EDLUAR 10 MG SL TABLET | Brand | $15.48 per each | $464.51 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $77.8 million for the 5 products below. That is down 10% from $86.4 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Zolpidem Tartrate* Zolpidem Tartrate | $50.1 million | 1,483,094 | $6.64 | $33.79 | $54.2 million |
| Zolpidem Tartrate ER Zolpidem Tartrate | $10.9 million | 76,620 | $29.49 | $142.83 | $11.6 million |
| Ambien Zolpidem Tartrate | $10.4 million | 2,323 | $786.40 | $4,463.85 | $13.0 million |
| Ambien Cr Zolpidem Tartrate | $5.7 million | 1,218 | $797.87 | $4,639.82 | $7.7 million |
| Edluar Zolpidem Tartrate | $739,195 | 232 | $606.39 | $3,186.18 | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 10 recall records that name zolpidem in the product description (8 Class II · 2 Class III).
Zolpidem Tartrate Extended-Release Tablets, USP 12.5mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-308-88.
Reason: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Zolpidem Tartrate Extended-Release Tablets, USP 6.25 mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-307-88.
Reason: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
ZOLPIDEM TARTRATE SUBLINGUAL TABLET 3.5 MG 30 UNIT DOSE POUCHES; NDC/UPC 49884089911; RX; EACH POUCH CONTAINS ONE SUBLINGUAL TABLET
Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Intermezzo (zolpidem tartrate) sublingual tablet 1.75 mg, CIV, 30 Ct Cartons, Rx Only. Dist by Purdue Pharma L.P., Stamford, CT 06901-3431. NDC: 59011-256-30.
Reason: Failed Dissolution Specifications
Zolpidem Tartrate Tablets, 10 mg Tablets, CIV, Packaged in A) 100 Count Bottles (NDC: 64679-715-01) and B) 500 Count Bottles (NDC: 64679-715-04), Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.
Reason: CGMP Deviations: Firm did not adequately investigate customer complaints.
Zolpidem Tartrate Tablets, 5 mg Tablets, CIV, Packaged in 100 Tablet Bottles, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-714-01.
Reason: CGMP Deviations: Firm did not adequately investigate customer complaints.
Intermezzo (zolpidem tartrate), sublingual tablet 3.5 mg, 1 tablet per pouch, 30 pouches per carton, Rx only, Distributed by Purdue Pharma L.P. Stamford, CT 06901-3431, NDC 59011-265-30
Reason: Failed dissolution specifications
ZOLPIDEM TARTRATE, Tablet, 2.5 mg (1/2 of 5 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 64679071401
Reason: Labeling: Label Mixup; ZOLPIDEM TARTRATE Tablet, 2.5 mg (1/2 of 5 mg) may be potentially mislabeled as TEMAZEPAM, Capsule, 7.5 mg, NDC 00378311001, Pedigree: AD22861_7, EXP: 5/8/2014.
Zolpidem Tartrate Tablets 5 mg, 10 tablets per blister, 10 blisters per carton, 100 cartons per box, Rx Only, Manufactured for Wockhardt USA LLC., Parsippany, NJ 07054 by Wockhardt Limited, Mumbai, India, NDC 68084-225-01
Reason: Unit Dose Mispackaging: This recall event is due to a random undetected packaging issue which could increase the potential for a small number of individual unit dose blisters to be packed with more than one tablet.
Northstar Zolpidem Tartrate Tablets USP 10 mg. Manufactured for Northstar RX, LLC Memphis, TN 38141. Manufactured by Aurobindo Pharma Limited, Unit VII, Mahaboob Dagar, 509302, India
Reason: Adulterated Presence of Foreign Tablets: This product is being recalled becaiuse 30 valacyclovir hydrochloride tablets USP 500 mg were discovered in a bottle labeled Zolpidem Tartrate tables USP 10 mg
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for zolpidem. This page is public-record information, not medical advice.